Skin manifestations in CDG

Journal of Inherited Metabolic Disease

Volumn 37, Issue 5, 2014, Pages 699-708

  Rymen, D ^a,b   Jaeken, J ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLICATION; CONGENITAL DISORDER OF GLYCOSYLATION; HUMAN; PATHOLOGY; SKIN; SKIN DISEASES;

CONGENITAL DISORDERS OF GLYCOSYLATION; HUMANS; SKIN; SKIN DISEASES;

EID: 84893821185     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-014-9678-7     Document Type: Review

References (59)

1. Avram MM (2004) Cellulite: a review of its physiology and treatment. J Cosmet Laser Ther 6(4):181–185
2. Berk DR, Bentley DD, Bayliss SJ, Lind A, Urban Z (2012) Cutis laxa: a review. J Am Acad Dermatol 66(5):842.e1–17
3. Bouvet C, Moreau S, Blanchette J, de Blois D, Moreau P (2008) Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol 28(5):856–862
4. Cartwright BR, Goodman JM (2012) Seipin: from human disease to molecular mechanism. J Lipid Res 53(6):1042–1055
5. Chefetz I, Sprecher E (2009) Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis. Biochim Biophys Acta 1792(9):847–852
6. Chefetz I, Kohno K, Izumi H, Uitto J, Richard G, Sprecher E (2009) GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity. Biochim Biophys Acta 1792(1):61–67
7. Chia KY, Tey HL (2013) Approach to hypohidrosis. J Eur Acad Dermatol Venereol 27(7):799–804
8. Dessinioti C, Stratigos AJ, Rigopoulos D, Katsambas AD (2009) A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol 18(9):741–749
9. Diao JS, Zhang X, Xia WS et al (2009) Aberrant Notch signaling: a potential pathomechanism of vitiligo. Med Hypotheses 73(1):70–72
10. Dou GR, Wang YC, Hu XB et al (2008) RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice. FASEB J 22(5):1606–1617
11. Elias PM, Williams ML, Feingold KR (2012) Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders. Clin Dermatol 30(3):311–322
12. Fischer B, Dimopoulou A, Egerer J et al (2012) Further characterization of ATP6V0A2-related autosomal recessive cutis laxa. Hum Genet 131(11):1761–1773
13. Groux-Degroote S, van Dijk SM, Wolthoorn J et al (2008) Glycolipid-dependent sorting of melanosomal from lysosomal membrane proteins by lumenal determinants. Traffic 9(6):951–963
14. Gründahl JEH, Guan Z, Rust S et al (2012) Life with too much polyprenol: polyprenol reductase deficiency. Mol Genet Metab 105(4):642–651
15. Hassed SJ, Wiley GB, Wang S et al (2012) RBPJ mutations identified in two families affected by Adams-Oliver syndrome. Am J Hum Genet 91(2):391–395
16. Hennet T (2012) Diseases of glycosylation beyond classical congenital disorders of glycosylation. Biochim Biophys Acta 1820(9):1306–1317
17. Hirata T, Fujita M, Kanzawa N, Murakami Y, Maeda Y, Kinoshita T (2013) Glycosylphosphatidylinositol mannosyltransferase II is the rate-limiting enzyme in glycosylphosphatidylinositol biosynthesis under limited dolichol-phosphate mannose availability. J Biochem 154(3):257–264. doi:10.1093/jb/mvt045
18. Hucthagowder V, Morava E, Kornak U et al (2009) Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival. Hum Mol Genet 18(12):2149–2165
19. Jaeken J, Matthijs G, Barone R, Carchon H (1997) Carbohydrate deficient glycoprotein (CDG) syndrome. J Med Genet 34:73–76
20. Jonas E, Schreinemachers HJ, Kleinwächter T et al (2008) QTL for the heritable inverted teat defect in pigs. Mamm Genome 19(2):127–138
21. Kahrizi K, Hu CH, Garshasbi M et al (2011) Next generation sequencing in a family with autosomal recessive Kahrizi syndrome (OMIM 612713) reveals a homozygous frameshift mutation in SRD5A3. Eur J Hum Genet 19(1):115–117
22. Kern A, Bryant-Greenwood GD (2009) Mechanisms of relaxin receptor (LGR7/RXFP1) expression and function. Ann N Y Acad Sci 1160:60–66
23. Krajnc-Franken MAM, Van Disseldorp AJM, Koenders JE, Mosselman S, Van Duin M, Gossen JA (2004) Impaired nipple development and parturition in LGR7 knockout mice. Mol Cell Biol 24(2):687–696
24. Lecca MR, Maag C, Berger EG, Hennet T (2011) Fibrotic response in fibroblasts from congenital disorders of glycosylation. J Cell Mol Med 15(8):1788–1796
25. Lefeber DJ, de Brouwer APM, Morava E et al (2011) Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation. PLoS Genet 7(12):e1002427
26. Leyvraz C, Charles RP, Rubera I et al (2005) The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol 170(3):487–496
27. Li M, Cheng R, Liang J et al (2013) Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized dowling-degos disease. Am J Hum Genet 92(6):895–903
28. Morava E, Zeevaert R, Korsch E et al (2007) A common mutation in the COG7 gene with a consistent phenotype including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia. Eur J Hum Genet 15(6):638–645
29. Moriyama M, Osawa M, Mak SS et al (2006) Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J Cell Biol 173(3):333–339
30. Ng BG, Hackmann K, Jones M et al (2012) Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. Am J Hum Genet 90(4):685–688
31. Ogawa R, Hsu CK (2013) Mechanobiological dysregulation of the epidermis and dermis in skin disorders and in degeneration. J Cell Mol Med 17(7):817–822. doi:10.1111/jcmm.12060
32. Okuyama R, Tagami H, Aiba S (2008) Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. J Dermatol Sci 49(3):187–194
33. Paller AS, van Steensel M, Rodriguez-Martín M et al (2011) Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism. J Invest Dermatol 131(11):2242–2248
34. Pinnix CC, Herlyn M (2007) The many faces of Notch signaling in skin-derived cells. Pigment Cell Res 20(6):458–465
35. Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E (2011) Calcinosis cutis: part II Treatment options. J Am Acad Dermatol 65(1):15–22
36. Reynders E, Foulquier F, Annaert W, Matthijs G (2011) How Golgi glycosylation meets and needs trafficking: the case of the COG complex. Glycobiology 21(7):853–863
37. Romero-Fernandez W, Borroto-Escuela DO, Alea MP, Garcia-Mesa Y, Garriga P (2011) Altered trafficking and unfolded protein response induction as a result of M3 muscarinic receptor impaired N-glycosylation. Glycobiology 21(12):1663–1672
38. Rymen D, Keldermans L, Race V et al (2012) COG5-CDG: expanding the clinical spectrum. Orphanet J Rare Dis 10(7):94
39. Rymen D, Peanne R, Millón MB et al (2013) MAN1B1 deficiency: an unexpected CDG-II. PLOS Genet 9(12):e1003989
40. Sakaidani Y, Nomura T, Matsuura A et al (2011) O-linked-N-acetylglucosamine on extracellular protein domains mediates epithelial cell-matrix interactions. Nat Commun 13(2):583
41. Schenk B, Imbach T, Frank CG et al (2001) MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. J Clin Invest 108(11):1687–1695
42. Shafir R, Bonne-Tamir B, Ashbel S, Tsur H, Goodman RM (1979) Genetic studies in a family with inverted nipples (mammillae invertita). Clin Genet 15(4):346–350
43. Shaheen R, Faqeih E, Sunker A et al (2011) Recessive mutations in DOCK6, encoding the guanidine nucleotide exchange factor DOCK6, lead to abnormal actin cytoskeleton organization and Adams-Oliver syndrome. Am J Hum Genet 89(2):328–333
44. Shaheen R, Aglan M, Keppler-Noreuil K et al (2013a) Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-Oliver syndrome. Am J Hum Genet 92(4):598–604
45. Shaheen R, Ansari S, Alshammari MJ et al (2013b) A novel syndrome of hypohidrosis and intellectual disability is linked to COG6 deficiency. J Med Genet 50(7):431–436
46. Simpson MA, Cross H, Proukakis C et al (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36(11):1225–1229
47. Southgate L, Machado RD, Snape KM et al (2011) Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies. Am J Hum Genet 88(5):574–585
48. Sprong H, Degroote S, Claessens T et al (2001) Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. J Cell Biol 155(3):369–380
49. Stahl M, Uemura K, Ge C, Shi S, Tashima Y, Stanley P (2008) Roles of Pofut1 and O-fucose in mammalian Notch signaling. J Biol Chem 283(20):13638–13651
50. Suzuki D, Yamada A, Amano T et al (2009) Essential mesenchymal role of small GTPase Rac1 in interdigital programmed cell death during limb development. Dev Biol 335(2):396–406
51. Tarutani M, Itami S, Okabe M et al (1997) Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci U S A 94(14):7400–7405
52. Terranova F, Berardesca E, Maibach H (2006) Cellulite: nature and aetiopathogenesis. Int J Cosmet Sci 28(3):157–167
53. Ungar D, Oka T, Brittle EE et al (2002) Characterization of a mammalian Golgi-localized protein complex, COG, that is required for normal Golgi morphology and function. J Cell Biol 157(3):405–415
54. Vauclair S, Nicolas M, Barrandon Y, Radtke F (2005) Notch1 is essential for postnatal hair follicle development and homeostasis. Dev Biol 284(1):184–193
55. Wang H, Bright A, Xin B, Bockoven JR, Paller AS (2013) Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency. Am J Med Genet A 161(4):875–879
56. Wu X, Steet R, Bohorov O et al (2004) Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat Med 10(5):518–523
57. Wu X, Quondamatteo F, Lefever T et al (2006) Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. Genes Dev 20(5):571–585
58. Yan Y, Scott DJ, Wilkinson TN, Ji J, Tregear GW, Bathgate RA (2008) Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function. Biochemistry 47(26):6953–6968
59. Zeevaert R, de Zegher F, Sturiale L et al (2013) Bone dysplasia as a key feature in three patients with a novel Congenital Disorder of Glycosylation (CDG) Type II due to a deep intronic splice mutation in TMEM165. JIMD Rep 8:145–152